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ABSTRACT  The  ability  of glycopeptides,  isolated  from  bovine  cerebral  cortex,  to  alter  cell 
division  was studied  by cell-cycle  analyses.  The results  showed that glycopeptides  arrested 
baby hamster kidney (BHK)-21  cells and Chinese hamster ovary (CHO) cells  in the G2 phase 
of the  cell  cycle.  Upon  removal  of the  growth  inhibition  from  arrested  BHK-21  cells,  the 
mitotic  index  in  colchicine-treated  cultures  increased  from  5  to  40%  within  6  h  and  the 
increase  in  mitotic  activity  was accompanied  by  a complete  doubling  of all  arrested  cells 
within this 6-h time period.  Determination  of DNA content in growth-arrested  BHK-21  cells 
showed that growth-arrested  cells  contained  about twice the  DNA of control  cell  cultures. 
Although CHO cells treated in a like manner with growth inhibitor could  not be arrested for 
the same length of time as BHK-21  cells  (18 h vs. 72 h before initiation of escape) and to the 
same  degree  (60% of the  cell  population  vs.  99% of  BHK-21  cells),  the  escape  kinetics  of 
CHO cells did indicate a G2 arrest. Approximately 3.5 h after escape began, CHO cell numbers 
in  treated  cultures  attained  the  cell  numbers  found  in  control  cultures.  This  rapid  growth 
phase occurring in less than 4 h indicated that the growth inhibitor induced a G~ arrest-point 
in CHO cells that was not lethal since the entire arrested cell population divided. 
There are many examples of cells in vivo stalled in the G~, 
putative Go, or the G2 phase of the cell cycle (9). Whereas in 
vivo cells are arrested by natural physiological causes, cells in 
culture can be arrested by various physical and physiological 
methods  including  ionizing  and  nonionizing  radiations, 
serum  and  nutrient  depletion,  topo-inhibition,  and  by the 
addition  of chemical agents such  as excess thymidine  and 
hydroxyurea (7,  10, 11, 12). To obtain an enriched population 
of G2 cells, either late-G~ blocking agents or toxic compounds 
have been utilized ( 11, 24, 25). These treatments have resulted 
in either poorly synchronized cultures passing through G2 or 
deleterious cell cycle events in which drug side effects cannot 
be overlooked, such as alterations in protein synthesis patterns 
and microtubule organization (24). 
More recently, however, a  search  for naturally occurring 
cellular products that can alter cellular growth and metabo- 
lism has been initiated.  Early reports suggested that macro- 
molecules associated with  the plasma membrane possessed 
this capacity to affect cell growth (3,  5, 8, 20,  31).  Exposure 
of cells to proteases could  result in  the  stimulation  of cell 
division (8) and, conversely, actively dividing cells could be 
inhibited in their growth rates if exposed to either conditioned 
medium or membrane fragments from confluent cell cultures 
(3 l, 32,  33). 
We  have  reported  the  isolation  and  characterization  of 
glycopeptides obtained from the mouse and/or bovine cere- 
bral cortex. These glycopeptides can inhibit cellular protein 
synthesis and  cell  division in  a  dose-dependent manner in 
various cell lines (13,  15). Furthermore, these growth-regulat- 
ing glycopeptides do not inhibit transformed cell lines such 
as murine fibrosarcoma cells or polyoma-transformed baby 
hamster kidney (BHK)~-21  cells (13,  14,  16). The inhibitor 
has been shown to be nonlethal,  completely reversible, and 
active at nanogram protein per milliliter concentrations (13, 
14,  15,  17). We  now  present  evidence  that  these  growth- 
regulating  glycopeptides isolated  from  the  bovine  cerebral 
cortex arrest both BHKo21  cells and Chinese hamster ovary 
(CHO) cells in the G2 phase of the cell cycle. 
MATERIALS  AND  METHODS 
BHK-21 cells (American Type Culture Collection,  RockviUe, MD) and CHO 
cells (obtained from Dr. D. Roufa, Kansas State  University)  were grown in 
Dulbecco's  modified Eagle's medium (DME) (Flow Laboratories, Inc., McLean, 
VA) containing 10% fetal calf serum (Kansas City Biologicals, Lenexa, KS) and 
J  Abbreviations  used  in  this  paper:  BHK,  baby hamster  kidney; 
CHO, Chinese hamster ovary; DME, Dulbecco's modified Eagle's 
medium; HKM, 20 mM HEPES, 120 mM KCI, and 5 mM MgCI2, 
pH 7.1. 
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© The Rockefeller University Press - 0021-9525/83/08/0311/06  $1.00  311 supplemented as described  (15) at 37" C in a humidified atmosphere of 5% 
CO2:95% air.  All cell cultures were propagated  in glass culture vessels and 
subcultured every fourth day to maintain the logarithmic growth. 
Preparation  of  GIycopeptide  Inhibitor:  Brains  from  freshly 
slaughtered cattle were kindly provided by the Department of Animal Science 
and Industry,  Kansas State University.  The procedure for isolating the growth 
inhibitory factor from the cerebral  cortex was similar to that previously de- 
scribed for material  prepared from the mouse and bovine cerebral cortex (14, 
16). The cerebral cortex gray matter was hand-dissected  from white matter and 
placed in ice cold DME containing 25 mM HEPES, pH 7.1. The cortical pieces 
obtained from the dissection  were minced by repetitive  pipetting until they 
were reduced to  ~ 1 mm  3.  Following centrifugation (200 g), the pellet  was 
resuspended in 0.02 U/m! of Streptomyces griseus protease (Sigma Chemical 
Co., St. Louis, MO) and incubated for 15 min at 37* C. After incubation, the 
tissue suspension was centrifuged  for 6 min, 500 g at 4* C. The supematant 
fraction  containing the released  macromolecules was then subjected  to two 
ethanol precipitations  at -20* C, concentrated by centrifugation  at 4,000 g, 
and  redissolved  in  distilled  water.  Lipids  were extracted with  chloroform/ 
methanol (2:1, vol/vol) and the aqueous phase was lyophilized.  The material 
obtained following lyophilization  was redissolved  in  HKM buffer (20  mM 
HEPES,  120 mM KCI, and 5 mM MgCI2, pH 7.1) to a concentration of 10 
mg/ml and applied to a Bio-Gel P-100 (Bio-Rad Laboratories,  Richmond, CA) 
column (2.5 x  100 cm). Fractions (5 ml) showing inhibition of  protein synthesis 
were pooled, ethanol precipitated, and redissolved in 3 ml of HKM buffer. The 
inhibitory material  was further purified by affinity chromatography on a  10 x 
l-cm Ulex  europeaus  agglutinin l-agarose column (UEA- 1, Vector Laboratories 
Inc., Burlingame, CA). The bound material was eluted from the lectin column 
by a step gradient of  0.1-0.5 M fucose containing 0.2% NaN3 in l-ml fractions 
and dialyzed at 4* C against  100 vol of HKM buffer (4 changes, 24 h), and 
then assayed for cell growth and protein synthesis inhibition activity. 
Protein Synthesis Inhibition Assay:  The detection ofmaterialthat 
can inhibit protein synthesis  has previously  been described (13,  14,  15,  17). 
Briefly, 25 #1 of material to be assayed was placed in disposable  13 x  100-mm 
tubes. 1  fl6 BHK-21 cells or CHO cells in 100 ~1 of DME-HEPES (pH 7. I) were 
added, and the tubes were covered and incubated at 37* C for 45 rain.  At the 
end of incubation, 2.0 #Ci of 35S-methionine in 10 #1 of DME-HEPES, pH 7.1, 
was added, and the tubes were covered and reincubated at 37* C for 1 h. Cells 
were then lysed with deionized water, and the macromolecules  were precipitated 
by the addition of an equal volume of 10% ice-cold trichloroacetic  acid and 
collected by centrifugation.  The supernatant fluid was discarded and the pellet 
resolubilized with I N NaOH, reprecipitated  with 10% trichloroacetic  acid, and 
collected by centrifugation.  Following the second wash, the precipitated mate- 
rial was resuspended in distilled water, resolubilized, and an aliquot was taken 
for liquid scintillation counting and another for protein determination (2) using 
BSA as a standard. 
Growth Inhibition Assay:  The procedure followed for the determi- 
nation of cell growth inhibition has previously  been described  (13). Briefly, 
either BHK-21 cells or CHO cells were plated in 24-well COSTAR tissue culture 
dishes (Bellco Glass, Inc., Vineland, NJ) at an initial density of 5 x  103 cells/ 
well, and after 24 h, the cultures were refed with either complete medium alone 
or complete medium containing various concentrations of glycopeptides pre- 
viously sterilized by filtration. 
Triplicate  samples were taken at least once every generation time by har- 
vesting cells with trypsin and diluted with isotonic saline, and the cells were 
counted with a Coulter counter model Zf (Coulter  Electronic  Inc.,  Hialeah, 
FL). 
Measurement  of  DNA  Content:  Cells  were  plated  in  12-well 
culture dishes at an initial density of 2.5 x  l04 cells/well. At 24 h, the growth 
inhibitor was added to a set of  wells. Immediately after addition and at specified 
times thereafter, cells were removed by scraping with a rubber policeman from 
the wells, centrifuged at 500 g, washed in HKM buffer and recentrifuged.  1.0 
ml of 1.0 N perchloric acid was added to the pellet. After sonication to rupture 
cellular and nuclear membranes, the suspension was heated for 30 min at 90* 
C. The resulting  suspension was centrifuged  at 2,000 g for 30 min, and the 
superuatant was assayed for DNA content by the procedure of Burton (4). 
Mitotic  Index  Determination:  Cells were  plated and  treated as 
described  above for growth inhibition assays. At 24  h following plating,  the 
medium from all wells was aseptically aspirated  and fresh complete medium 
was added. At intervals, colchicine was added to a final concentration of l0  -~ 
M  for 3 h, and then removed. The cells were washed with a  balanced salt 
solution,  fixed with Caruoy's as described by Dille et al. (6), and stained with 
crystal  violet.  A  minimum of 1,000 cells/time point was  counted and the 
percent of cells in metaphase determined. 
RESULTS 
Preliminary  experiments  were  carried  out  to  determine 
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whether the growth regulating glycopeptides could be titrated, 
in a  dose-dependent  manner,  in the growth-inhibition assay. 
BHK-21 cells were plated and treated with various concentra- 
tions of bovine glycopeptides, and,  following a  24-h  incuba- 
tion period, cell numbers  were measured and compared  with 
cell numbers  in untreated control cultures.  Under  the condi- 
tions of this assay, the glycopeptides inhibited cell growth by 
50%,  using a  concentration of <50  ng protein/ml. A  concen- 
tration of 160 ng protein/ml resulted in cell growth inhibition 
of over 90%  as compared  with control cultures to which no 
inhibitor was added (Fig.  1). 
Growth Studies 
Cell growth inhibition of both BHK-21  cells and CHO  cells 
was monitored  beginning one generation time following plat- 
ing.  The  glycopeptide inhibitor was added  (160  ng protein/ 
ml)  and  the  inhibition  of cell growth  as determined  by cell 
number  was measured.  Inhibition of cell growth in BHK-21 
cells  was  observed  within  24  h,  whereas  control  cultures 
continued  to  grow  with  a  doubling  time  of 27  h  (Fig.  2). 
Furthermore,  inhibition of cell growth was maintained  for an 
additional  24  h  for a  total  arrest  time  of 48  h.  During  this 
time, the cell density in the treated cultures was  ~  1.2  x  l04 
cells/cm  2,  whereas  the  cell  density  40  h  after  the  medium 
change was ~3  x  l04 cells/cm  2. Removal  ofglycopeptides at 
48  h  after their  addition  resulted  in  a  rapid  increase in  cell 
number  within  6  h  (Fig.  2).  The  kinetics  of  cell  division 
following removal  of the  inhibitor showed that  most  of the 
cells were  arrested at  a  specific point  in  the  cell  cycle.  The 
results also indicated that the inhibitor was not lethal to BHK- 
21  cells  because  a  complete  doubling  of cell  number  was 
observed (Fig.  2).  This  rate of cell division following release 
from  growth  inhibition  was  representative  of a  population 
stalled and synchronized in G> At the end of the rapid growth 
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FIGURE  1  Titration  of  cell  growth  inhibition  activity  by  bovine 
cerebral cortex glycopeptides. BHK-21  cells were plated and al- 
lowed to grow for 24 h,  at which time various concentrations of 
inhibitor were added. The  percent inhibition of cell growth was 
determined by comparing cell  numbers  in  treated cultures  24  h 
after treatment with cell numbers in control cultures. Each point is 
the average of three experiments and the vertical bars  represent 
ranges. o 
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Inhibition of BHK-21  cell growth by glycopeptides. Ap- 
proximately  104 cells  were  plated  as  described  in  Materials and 
Methods followed by addition of inhibitor (160 ng protein/ml) 24 
h later. After two generation times, the inhibitor was removed and 
fresh medium added. (Control, solid circles; treated, open circles.) 
Each  point is the average and  range of triplicate samples for two 
experiments. 
phase,  there was a  plateauing of cell  number as these cells 
exited  mitosis and entered the ensuing GI phase. 
The observation that growth-arrested BHK-21  cells  were 
stalled at a specific point in G2 was confirmed when additional 
inhibitor was added 2 h after cell number began to increase 
and the rate of cell  division could not be altered (data not 
shown).  This  indicated the  existence  of a  restriction  point 
located in G2. 
Experiments were also performed to determine the length 
of time that BHK-21 cells could be arrested  in growth by the 
inhibitor. During these experiments, the inhibitor was never 
removed.  As  shown  in  Fig.  3,  BHK-21  cells  were  growth 
arrested for up to 66 h before cells escaped from the inhibition. 
A comparison of the kinetics  of cell growth in these  experi- 
ments with results  obtained from reversal  experiments (Fig. 
2) showed a  similar increase  in cell  number.  That is,  there 
was a  rapid increase  in cell  number,  with over 99%  of the 
population doubling in a short period of time. 
Determination of Mitotic Index 
Further  analysis  was  performed to  determine  the  actual 
degree  of synchronization in  BHK-21  cells  in  response  to 
growth-regulating glycopeptides.  The mitotic index was deter- 
mined following treatment with  l0  -5 M colchicine for 3 h to 
collect  cells  at  metaphase.  Cultures  were  then  fixed  with 
Carnoy's fixative  and stained with crystal violet.  Using the 
same procedures, the mitotic index in control cultures,  not 
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FIGURE 3  Escape  from  growth inhibition by BHK-21 cells. Cells 
were plated and treated as described for Fig. 2; however, inhibitor 
was  present  for  the  duration of the  experiment. (Control,  solid 
circles; treated, open circles.) 
synchronized and growing exponentially, was calculated to be 
9%. In cultures treated with glycopeptides,  the mitotic index 
decreased  from  45  to  5%  within  12  h  (Fig.  4).  Then  the 
inhibitor was removed and fresh medium was added. Within 
6 h after removal, the mitotic index increased to over 40% 
and this increased mitotic activity corresponded to the rapid 
growth rate observed in BHK-21 cells (Fig. 2). At this time, 
the  mitotic  index  began  to  decrease  to  5%,  which  corre- 
sponded to the plateau observed after reversal  was complete 
and the newly divided cells entered the next cell cycle. 
DNA Content in Growth-arrested  BHK-21 
Cell Cultures 
We obtained final verification that the cell population was 
blocked  in  G2  by  determining  the  total  DNA  content  in 
growth-arrested  BHK-21  cell  cultures  and  comparing this 
amount with  the  DNA content measured  in  control, loga- 
rithmically growing,  populations. As shown in Table I, the 
average DNA content in control cultures was measured to be 
24 pg/cell.  In cell cultures treated with the bovine glycopep- 
tides for 24 h, which resulted  in maximum growth inhibition 
when the DNA content was 42 pg/cell, a 1.8-fold increase was 
observed.  The DNA content in treated populations was also 
measured 10 h after reversal, when the majority of  the growth- 
arrested cells had doubled. In these cultures,  the DNA content 
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FIGURE  4  Mitotic index of growth-inhibited and reversed cultures 
of BHK-21 cells. The glycopeptide inhibitor was added 24 h follow- 
ing plating and removed after treatment for 12 h. The mitotic index 
was determined by treating cultures with  10  -s M  colchicine for 3 h 
prior to staining with  crystal  violet. A  minimum  of  103  cells was 
counted for each time point. 
obtained with  BHK-21  cells were  due to a  property of the 
BHK-21 cell line  or a general  characteristic of these  bovine 
cerebral  glycopeptides.  The glycopeptides were  added  to  a 
final  concentration of 160 ng protein/ml,  previously deter- 
mined to be the optimal concentration for the inhibition of 
CHO cell growth (data not shown).  As shown in Fig. 5, the 
pattern  of growth  arrest  in  CHO  cells  differed  from  that 
observed with BHK-21 cells (Fig. 2). Cell growth of  CHO cells 
was not completely inhibited,  for ~ 30% of  the cell population 
continued to divide.  Addition of inhibitor at either higher or 
lower concentrations (8-1,000 ng protein/ml) did not arrest 
this  population.  Furthermore,  the  cells  that were  inhibited 
escaped  the  growth  arrest  <20  h  after  addition  of bovine 
inhibitor. The length of inhibition could not be extended by 
the  addition  of fresh  inhibitor  alone  or  in  fresh  complete 
medium.  Likewise,  addition  of inhibitor just  after  escape 
began could not delay the escape and subsequent increase  in 
cell  number.  As the  cells  escaping from the  growth arrest 
began  to  divide,  the  kinetics  indicates  a  synchronized cell 
population stalled in G2, for there was a rapid increase in cell 
number in a period of<5 h. The rapid increase in cell number 
also  demonstrated  that  the  glycopeptide inhibitor  was  not 
lethal  to CHO cells and  was  completely reversible,  for the 
growth-arrested cell population quickly attained cell numbers 
comparable with control cell cultures. 
Further evidence that CHO cells were  blocked in the G2 
phase of the cell cycle was obtained after the DNA content in 
the  treated  cultures was  measured  and  compared with  the 
DNA content in logarithmically growing cell populations. In 
these experiments, the logarithmically growing cells contained 
~49 pg DNA/ceI1, whereas CHO cells treated with  200 ng 
inhibitor protein/ml for 12 h contained ~ 76 pg DNA/cell or 
1.5 times more DNA than the untreated control cultures (data 
TABLE  I 
DNA Content in BHK-21 Cells Treated with Growth-regulating 
Glycopeptides* 
Time  Control  Treated  T/C 
(h) 
0  23 4- 3.5 
24  24.4 ___ 3.7 
38  Not determined 
48  24.3 +_ 3.2 
Control  Ave  __-  23.9 ___ 0.8 
SD 
21  --- 2.8  0.9 
41.9 -+ 9.9  1.8 
22.5 ----- 2.5  0.9 
19.5  ----- 4.4  0.8 
* The concentration  of glycopeptides was 160 ng protein/ml for  104 cells, 
and a minimum of 2 x  105 cells/determination.  DNA was determined by the 
diphenylamine assay of Burton (4). 
decreased  to  ~23  pg/cell,  and,  when  measured  20  h  after 
reversal, was determined to be ~20 pg/cell,  which suggested 
that the  arrested  cell  population largely  remained synchro- 
nized. 
From these and the preceding data, it was confirmed that 
growth-regulating glycopeptides did arrest nonconfluent cul- 
tures of BHK-21 cells in the G2 phase of the cell cycle and 
that the material was nonlethal and reversible in its effects on 
cell growth. 
Studies  with  CHO  Cell Cultures 
Experiments  similar  to  those  described  above were  per- 
formed  with  CHO  cells  to  determine  whether  the  results 
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FIGURE  5  Growth inhibition in CliO cell cultures by brain glyco- 
peptides. CHO cells were plated and an initial density of 5  x  103 
cells/well  with  a  plating  efficiency  calculated  to  be  70%.  The 
inhibitor was added to an optimal concentration of 160 ng protein/ 
ml at 31  h following plating. Each point represents the average and 
range of triplicate determinations from two experiments. (Control, 
solid circles; treated, open circles.) 
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to 20%  following removal of the bovine inhibitor (data not 
shown), indicating that the growth-arrested CHO cells were 
indeed blocked in G2. 
DISCUSSION 
The glycopeptides used in  this  study have previously been 
described (14) and their ability to inhibit protein synthesis has 
been  well  documented  (13-17).  It is  of particular interest, 
however, that two major actions of these glycopeptides, cell- 
growth  inhibition  and  the  inhibition  of protein  synthesis, 
copurify through  affinity chromatography with  UEA-I col- 
umns (14,  18). In addition, cell lines that are refractory in the 
assay for the inhibition of protein synthesis also appear to be 
uninhibited in cell-growth assays (13,  16). This strongly sug- 
gests that there is a close association between the inhibition 
of protein synthesis and the inhibition of the division process. 
Although the mechanism by which bovine brain glycopep- 
tides block nonconfluent cultures of BHK-21 cells and CHO 
cells is not yet clear, we have observed a number of interesting 
phenomena associated with their effects on cellular processes. 
During the titration of growth inhibition by these glycopep- 
tides using BHK-21 cells, the inhibition of cell growth appears 
to follow saturation kinetics. Results were similar for the assay 
of protein synthesis inhibition in which the total number of 
binding sites per BHK-21  cell was calculated to be 7  x  l05 
(13).  From these data, we achieved maximum inhibition of 
cell growth  with  a  maximum of 250  molecules of growth 
inhibitor per binding  site.  The  same effects were  observed 
when  CHO cells were used.  Although  the  CHO cells have 
been selected to grow in  monolayer cultures and to be an- 
chorage dependent (D. Roufa, personal communication), it is 
possible that the  transient  nature  of the G2  arrest in  these 
CHO  cells  is  related  to  the  presence of a  C-type virus  or 
chromosome marker (19,  29).  Furthermore, both cell lines, 
when treated with fresh glycopeptides prior to escape or during 
the  process  of escape,  could  not  be  delayed  beyond  this 
preprogrammed time. While the explanation for the inability 
of bovine cerebral glycopeptides to delay escape for an ex- 
tended period of time is not clear, it is obvious that, as a G2 
blocker,  these  glycopeptides  cannot  block  cells  that  have 
passed the growth restriction point. Therefore, once cells had 
initiated escape, progression through the remainder of the cell 
cycle  would  occur.  After  inhibited  cells  had  divided  and 
attained the cell numbers of control cultures, we also observed 
a  plateau  in  treated  cell  cultures.  This  indicated  that  the 
treated cell population was still synchronized for a period of 
time after division. Earlier, it was observed that at least two 
rounds  of synchronized  cell  division  could  be induced  by 
these glycopeptides (14).  Examination of the mitotic index, 
however, did not indicate as perfect a synchrony as the cell 
number  increase  would  indicate  since  the  mitotic  index 
peaked at 40%. This can be explained by the fact that samples 
for the mitotic index were treated for 12 h, or 45% of the cell 
cycle, with  inhibitor.  The  mitotic index  of 40%,  therefore, 
indicates  that  over  85%  of the  inhibited  cells  progressed 
through mitosis in a synchronized manner. 
Holley (12) has suggested that in the case of mouse 3T3 
fibroblasts control of growth is regulated more through deple- 
tion of serum factors than by production or lack of  production 
of growth regulators. Work by Glaser (20,  21,  33,  34),  how- 
ever, has provided evidence to the contrary, for it was shown 
that material from either conditioned medium or cell mem- 
brane  fragments could  inhibit  cell  growth.  Similar  studies 
using material from other sources have also shown the possible 
presence of growth  inhibitory  substances  (10,  22,  23,  24). 
Although these studies used the incorporation of [3H]thymi- 
dine into DNA as a  marker for changes in cellular growth, 
they have not identified a new cell cycle inhibitor, for little,  if 
any, cell cycle kinetics have been performed in these studies. 
The manifestations of growth-regulating glycopeptides act- 
ing as G2 arresting agents are numerous. Pardee (25)  stated 
evidence for a  cell cycle control point in G2, albeit a weak 
control point. The evidence arises from the ability ofdibutyryl 
cAMP, when added to some cells,  to block the cycle in G2 
(30).  Other attempts to arrest cycling cells in G2 have used 
nitrosourea  compounds  (26)  or  toxic  chemotherapeutic 
agents, many of which affect the cellular genome (1). It is for 
these reasons that the potential use of bovine brain glycopep- 
tides is important. Without the ability to obtain a truly G2- 
synchronized mammalian cell population, that is, without the 
use of a nontoxic and completely reversible, naturally occur- 
ring molecule, final mapping of division-directing events can- 
not be ascertained. The identification of a cell-surface com- 
ponent that stalls cell division in the G2 phase of the mitotic 
cycle may be far from artificial since a considerable number 
of cells are normally stalled in such a manner (9). The reasons 
for a cell-cycle restriction point in G2 are presently unknown. 
However, the observations that progression through G2 could 
be inhibited by fusion of a G2 cell with a cell from an earlier 
phase  of the  cycle  (27)  and  the  requirement  for  protein 
synthesis preceding  mitosis (28)  suggest  the  existence  of a 
naturally occurring control point in G2. 
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